title: Safety of donor in adult-to-adult living donor liver transplantation using right lobe graft.
abstract: BACKGROUND
  The growing gap between the number of patients awaiting liver transplantation and available organs has continued to be the primary issue facing the transplant community. To overcome the waiting list mortality, living donor liver transplantation has become an option, in which the greatest concern is the safety of the donor, especially in adult-to-adult living donor liver transplantation (A-A LDLT) using a right lobe liver graft.
  
  
  OBJECTIVE
  We evaluated the safety of donors after right lobe liver donation for A-A LDLT performed in our center.
  
  
  METHODS
  From January 2002 to March 2006, 26 patients underwent A-A LDLT using right lobe liver grafts in our center. Seven donors were men and 19 were women (range, 19-65 years; median age, 38 years). The right lobe liver grafts were obtained by transecting the liver on the right side of the middle hepatic vein without interrupting the vascular blood flow. The mean follow-up time for these donors was 9 months.
  
  
  RESULTS
  These donor residual liver volumes ranged from 30.5% to 60.3%. We did not experience any donor mortality. Two cases (7.69%) experienced major complications: intra-abdominal bleeding and portal vein thrombosis in one each and three (11.54%), minor ones: wound steatosis in two, and transient chyle leak in one. All donors were fully recovered and returned to their previous occupations.
  
  
  CONCLUSIONS
  A-A LDLT using a right lobe liver graft has become a standard option. The donation of right lobe liver for A-A LDLT was a relatively safe procedure in our center.
authors.affiliation: Center of Liver Transplantation, West China Hospital, Sichuan University, Chengdu, PR China.
authors.forename: X-Z
authors.initials: XZ
authors.lastname: Jiang
authors.forename: L-N
authors.initials: LN
authors.lastname: Yan
authors.forename: B
authors.initials: B
authors.lastname: Li
authors.forename: T-F
authors.initials: TF
authors.lastname: Wen
authors.forename: Y
authors.initials: Y
authors.lastname: Zeng
authors.forename: W-T
authors.initials: WT
authors.lastname: Wang
authors.forename: J-C
authors.initials: JC
authors.lastname: Zhao
authors.forename: J-Y
authors.initials: JY
authors.lastname: Yang
authors.forename: M-Q
authors.initials: MQ
authors.lastname: Xu
authors.forename: Y-K
authors.initials: YK
authors.lastname: Ma
authors.forename: Z-Y
authors.initials: ZY
authors.lastname: Chen
authors.forename: F-G
authors.initials: FG
authors.lastname: Li
mesh_terms: D000328:Adult; D000368:Aged; D005190:Family; D005260:Female; D006498:Hepatectomy / Q000379:methods*; D006801:Humans; D008099:Liver / Q000033:anatomy & histology; D016031:Liver Transplantation / Q000379:methods*; D019520:Living Donors / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012449:Safety; D020858:Tissue and Organ Harvesting / Q000379:methods*; D016896:Treatment Outcome